Phase 2 Study of HEC88473 Injection in Subjects With Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Interventions: Drug: HEC88473, Placebo, Dulaglutide Sponsors: Dongguan HEC Biopharmaceutical R&D Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2023 Category: Research Source Type: clinical trials
Pilot Evaluation of Algorithms for Detection of Insulin Pump Malfunctions
Conditions: Diabetes Mellitus, Type I Interventions: Other: Simulation of an insulin pump failure Sponsors: University of Padova; Azienda Ospedaliera di Padova Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2023 Category: Research Source Type: clinical trials
Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia
Conditions: Nephropathy; Diabetic Nephropathies; Diabetes Mellitus, Type 1; Albuminuria; Diabetic Complications Renal; Diabetic Complications Cardiovascular; Hypoxia Interventions: Drug: Sotagliflozin; Drug: Placebo Sponsors: Steno Diabetes Center Copenhagen; Juvenile Diabetes Research Foundation; King ' s College London; Glostrup University Hospital, Copenhagen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2023 Category: Research Source Type: clinical trials
Effects of Different'' Exercise Snacking'' Modalities on Glycemic Control in Patients With Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2; Overweight or Obesity Interventions: Behavioral: HIIT snacks; Behavioral: Sprint snacks; Other: Control Sponsors: University of Nis Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2023 Category: Research Source Type: clinical trials
Evaluating the Efficacy and Safety of Empagliflozin Addition to Insulin and Oral Antidiabetic Medication (OAD) Regimen in Poorly Controlled Type 2 Diabetes and Obese Patient
Conditions: Glucose Metabolism Disorders; Diabetes Mellitus, Type 2; Hypoglycemic Agents; Empagliflozin Interventions: Drug: Empagliflozin 10 MG; Drug: Insulin+Metformin+DPP4 inhibitor (DPP4I) Sponsors: SINA Health Education and Welfare Trust; Horizon Pharmaceutical Pvt Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2023 Category: Research Source Type: clinical trials
Taiwan Diabetes Registry
Conditions: Diabetes Mellitus Interventions: Other: Observational study - registry Sponsors: The Diabetes Association of the Republic of China (Taiwan) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
Evaluation of Efficacy and Safety When Administered JP-2266 in Type 2 Diabetes Patients
Conditions: Type 2 Diabetes Mellitus Interventions: Drug: SGLT2 inhibitor Sponsors: Jeil Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
The Metabolic Impact of Intermittent Carbohydrate Restriction in Individuals With Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2; Overweight and Obesity; Non-Alcoholic Fatty Liver Disease; Metabolic Syndrome Interventions: Other: Dietary macronutrient composition Sponsors: Hvidovre University Hospital; University of Copenhagen; Danish Research Centre for Magnetic Resonance Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
To Investigate the Risk Factors, Life Style and Treatments of the Microvascular Disease ，Macrovascular Disease and Neuropathy in Patients With Diabetes.
Conditions: Diabetes Mellitus Interventions: Other: Observational study - registry Sponsors: The Diabetes Association of the Republic of China (Taiwan) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
A Clinical Trial of AP026 (TQA2226) for Injection in Adult Subjects.
Conditions: Diabetes Mellitus, Type 2 Interventions: Drug: AP026 (TQA2226) for injection; Drug: AP026 (TQA2226) for injection matching placebo Sponsors: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
A Pilot Study to Test the Diabetes Staging System (DSS) in Patient Aligned CareTeams (PACT) Teams
Conditions: Diabetes Mellitus; Type 2 Diabetes Interventions: Other: Diabetes Staging System (DSS) use among Primary Care Teams Sponsors: Durham VA Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
A Clinical Study to Evaluate the Safety and the Pharmacokinetics of UI068 in Healthy Adult Volunteers Under Fed Conditions
Conditions: Diabetes Mellitus, Type 2 Interventions: Drug: administration of UI068; Drug: administration of UIC202205, UIC202206 Sponsors: Korea United Pharm. Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes Mellitus
Conditions: T2DM (Type 2 Diabetes Mellitus) Interventions: Drug: DWP16001 0.3 mg Sponsors: Daewoong Pharmaceutical Co. LTD. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
A Trial to Investigate the Efficacy and Safety of NW Low-Glu ® in Patients With Type II Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2 Interventions: Dietary Supplement: NW Low-Glu ®; Drug: Metformin Sponsors: Natural Wellness Egypt Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 20, 2023 Category: Research Source Type: clinical trials
A Phase III RCT to Investigate the Efficacy and Safety of NW Low-Glu ® in Patients With Type II Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2 Interventions: Dietary Supplement: NW Low-Glu ®; Drug: Metformin Sponsors: Natural Wellness Egypt Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 20, 2023 Category: Research Source Type: clinical trials
